ARRAY BIOPHARMA
Array BioPharma is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company partnered drugs are binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology), and tucatinib (partnered with Cascadian Therapeutics). The company is committed to providing therapies to patients. Array BioPharma was founded on 1998 and is headquartered in Boulder, Colorado.
ARRAY BIOPHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
1998-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.arraybiopharma.com
Total Employee:
51+
Status:
Closed
Contact:
303.381.6600
Email Addresses:
[email protected]
Total Funding:
121.4 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Google Maps Microsoft Azure DNS Google Maps API Microsoft IIS 7
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Redmile Group
Redmile Group investment in Post-IPO Equity - Array BioPharma
Deerfield
Deerfield investment in Post-IPO Debt - Array BioPharma
Deerfield
Deerfield investment in Post-IPO Debt - Array BioPharma
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Venture Round - Array BioPharma
Official Site Inspections
http://www.arraybiopharma.com
- Host name: 192.29.61.237
- IP address: 192.29.61.237
- Location: Zurich Switzerland
- Latitude: 47.4049
- Longitude: 8.4631
- Timezone: Europe/Zurich
- Postal: 8102
